AKTSAktis Oncology, Inc.
- Market cap
- $874.89M
- as of 2026-10-23
- Latest close
- $15.73
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2026-01-12
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Czibere AkosChief Medical Officer | Sep 23 | Sep 24 | M | 12,500 | $4.95 | $61,875 | 12,500 | Yes | Form 4 |
| Czibere AkosChief Medical Officer | Sep 23 | Sep 24 | S | 5,099 | $20.19 | Sale −$102,949 | 7,401 | Yes | Form 4 |
| Czibere AkosChief Medical Officer | Sep 23 | Sep 24 | S | 7,401 | $21.03 | Sale −$155,643 | not reported | Yes | Form 4 |
| Czibere AkosChief Medical Officer | Sep 23 | Sep 24 | M · derivative | 12,500 | $4.95 | $61,875 | 208,718 | Yes | Form 4 |
| Herrmann Ken | Jul 20 | Jul 21 | M | 3,506 | $0.08 | $280 | 3,506 | No | Form 4 |
| Herrmann Ken | Jul 20 | Jul 21 | M | 1,350 | $1.91 | $2,579 | 4,856 | No | Form 4 |
| Herrmann Ken | Jul 20 | Jul 21 | S | 3,506 | $24.56 | Sale −$86,107 | 1,350 | No | Form 4 |
| Herrmann Ken | Jul 20 | Jul 21 | S | 1,350 | $24.56 | Sale −$33,156 | not reported | No | Form 4 |
| Herrmann Ken | Jul 20 | Jul 21 | M · derivative | 3,506 | $0.08 | $280 | not reported | No | Form 4 |
| Herrmann Ken | Jul 20 | Jul 21 | M · derivative | 1,350 | $1.91 | $2,579 | 18,364 | No | Form 4 |
| Herrmann Ken | Jul 17 | Jul 20 | M | 3,065 | $0.08 | $245 | 3,065 | No | Form 4 |
| Herrmann Ken | Jul 17 | Jul 20 | S | 3,065 | $25.21 | Sale −$77,269 | not reported | No | Form 4 |
| Herrmann Ken | Jul 17 | Jul 20 | M · derivative | 3,065 | $0.08 | $245 | 3,506 | No | Form 4 |
| Czibere AkosChief Medical Officer | Jul 8 | Jul 10 | M | 50,000 | $4.95 | $247,500 | 50,000 | No | Form 4 |
| Czibere AkosChief Medical Officer | Jul 8 | Jul 10 | S | 14,800 | $27.13 | Sale −$401,524 | 35,200 | No | Form 4 |
| Czibere AkosChief Medical Officer | Jul 8 | Jul 10 | S | 30,829 | $27.95 | Sale −$861,671 | 4,371 | No | Form 4 |
| Czibere AkosChief Medical Officer | Jul 8 | Jul 10 | S | 4,371 | $28.71 | Sale −$125,491 | not reported | No | Form 4 |
| Czibere AkosChief Medical Officer | Jul 8 | Jul 10 | M · derivative | 50,000 | $4.95 | $247,500 | 221,218 | No | Form 4 |
| Ron-Bigger ShulamitChief Operating Officer | Jul 8 | Jul 10 | M | 50,000 | $3.66 | $183,000 | 50,000 | No | Form 4 |
| Ron-Bigger ShulamitChief Operating Officer | Jul 8 | Jul 10 | S | 15,800 | $27.13 | Sale −$428,654 | 34,200 | No | Form 4 |
| Ron-Bigger ShulamitChief Operating Officer | Jul 8 | Jul 10 | S | 30,000 | $27.94 | Sale −$838,200 | 4,200 | No | Form 4 |
| Ron-Bigger ShulamitChief Operating Officer | Jul 8 | Jul 10 | S | 4,200 | $28.75 | Sale −$120,750 | not reported | No | Form 4 |
| Ron-Bigger ShulamitChief Operating Officer | Jul 8 | Jul 10 | M · derivative | 50,000 | $3.66 | $183,000 | 217,888 | No | Form 4 |
| Gormley Glenn | Apr 15 | Apr 16 | A · derivative | 37,866 | $18.09 | $684,996 | 37,866 | No | Form 4 |
| Gadicke Ansbert | Jan 12 | Jan 14 | C | 1,314,262 | not reported | not reported | 1,655,971 | No | Form 4 |
| Gadicke Ansbert | Jan 12 | Jan 14 | C | 5,914,197 | not reported | not reported | 7,570,168 | No | Form 4 |
| Gadicke Ansbert | Jan 12 | Jan 14 | C | 1,577,119 | not reported | not reported | 9,147,287 | No | Form 4 |
| Gadicke Ansbert | Jan 12 | Jan 14 | P | 1,112,777 | $18.00 | Purchase +$20,029,986 | 10,260,064 | No | Form 4 |
| Gadicke Ansbert | Jan 12 | Jan 14 | C · derivative | 5,000,000 | $0.00 | $0 | not reported | No | Form 4 |
| Gadicke Ansbert | Jan 12 | Jan 14 | C · derivative | 22,500,000 | $0.00 | $0 | not reported | No | Form 4 |
| Gadicke Ansbert | Jan 12 | Jan 14 | C · derivative | 6,000,000 | $0.00 | $0 | not reported | No | Form 4 |
| Mpm Oncology Innovations Fund LP | Jan 12 | Jan 14 | C | 1,314,262 | not reported | not reported | 1,655,971 | No | Form 4 |
| Mpm Oncology Innovations Fund LP | Jan 12 | Jan 14 | C | 5,914,197 | not reported | not reported | 7,570,168 | No | Form 4 |
| Mpm Oncology Innovations Fund LP | Jan 12 | Jan 14 | C | 1,577,119 | not reported | not reported | 9,147,287 | No | Form 4 |
| Mpm Oncology Innovations Fund LP | Jan 12 | Jan 14 | P | 1,112,777 | $18.00 | Purchase +$20,029,986 | 10,260,064 | No | Form 4 |
| Mpm Oncology Innovations Fund LP | Jan 12 | Jan 14 | C · derivative | 5,000,000 | $0.00 | $0 | not reported | No | Form 4 |
| Mpm Oncology Innovations Fund LP | Jan 12 | Jan 14 | C · derivative | 22,500,000 | $0.00 | $0 | not reported | No | Form 4 |
| Mpm Oncology Innovations Fund LP | Jan 12 | Jan 14 | C · derivative | 6,000,000 | $0.00 | $0 | not reported | No | Form 4 |
| Foley Todd | Jan 12 | Jan 14 | C | 597,391 | not reported | not reported | 597,391 | No | Form 4 |
| Foley Todd | Jan 12 | Jan 14 | C | 2,688,270 | not reported | not reported | 3,285,661 | No | Form 4 |
| Foley Todd | Jan 12 | Jan 14 | C | 716,872 | not reported | not reported | 4,002,533 | No | Form 4 |
| Foley Todd | Jan 12 | Jan 14 | P | 232,870 | $18.00 | Purchase +$4,191,660 | 4,235,403 | No | Form 4 |
| Foley Todd | Jan 12 | Jan 14 | C · derivative | 2,272,727 | $0.00 | $0 | not reported | No | Form 4 |
| Foley Todd | Jan 12 | Jan 14 | C · derivative | 10,227,273 | $0.00 | $0 | not reported | No | Form 4 |
| Foley Todd | Jan 12 | Jan 14 | C · derivative | 2,727,273 | $0.00 | $0 | not reported | No | Form 4 |
| Nodelman Oleg | Jan 12 | Jan 12 | C | 2,270,879 | not reported | not reported | 2,270,879 | No | Form 4 |
| Nodelman Oleg | Jan 12 | Jan 12 | C | 202,862 | not reported | not reported | 202,862 | No | Form 4 |
| Nodelman Oleg | Jan 12 | Jan 12 | C | 128,506 | not reported | not reported | 128,506 | No | Form 4 |
| Nodelman Oleg | Jan 12 | Jan 12 | P | 2,077,779 | $18.00 | Purchase +$37,400,022 | 4,348,658 | No | Form 4 |
| Nodelman Oleg | Jan 12 | Jan 12 | P | 144,443 | $18.00 | Purchase +$2,599,974 | 347,305 | No | Form 4 |
| Nodelman Oleg | Jan 12 | Jan 12 | C · derivative | 9,913,810 | not reported | not reported | not reported | No | Form 4 |
| Nodelman Oleg | Jan 12 | Jan 12 | C · derivative | 997,299 | not reported | not reported | not reported | No | Form 4 |
| Nodelman Oleg | Jan 12 | Jan 12 | C · derivative | 488,891 | not reported | not reported | not reported | No | Form 4 |
| Nodelman Oleg | Jan 12 | Jan 12 | C · derivative | 2,397,500 | not reported | not reported | not reported | No | Form 4 |
| Nodelman Oleg | Jan 12 | Jan 12 | C · derivative | 102,500 | not reported | not reported | not reported | No | Form 4 |
| Nodelman Oleg | Jan 12 | Jan 12 | C · derivative | 965,190 | not reported | not reported | 965,190 | No | Form 4 |
| Nodelman Oleg | Jan 12 | Jan 12 | C · derivative | 86,222 | not reported | not reported | 86,222 | No | Form 4 |
| Kim Helen Susan | Jan 12 | Jan 12 | C | 4,859,370 | not reported | not reported | 4,859,370 | No | Form 4 |
| Kim Helen Susan | Jan 12 | Jan 12 | P | 812,455 | $18.00 | Purchase +$14,624,190 | 5,671,825 | No | Form 4 |
| Kim Helen Susan | Jan 12 | Jan 12 | C | 134,842 | not reported | not reported | 134,842 | No | Form 4 |
| Kim Helen Susan | Jan 12 | Jan 12 | P | 22,545 | $18.00 | Purchase +$405,810 | 157,387 | No | Form 4 |
| Kim Helen Susan | Jan 12 | Jan 12 | C · derivative | 14,838,250 | $0.00 | $0 | not reported | No | Form 4 |
| Kim Helen Susan | Jan 12 | Jan 12 | C · derivative | 411,750 | $0.00 | $0 | not reported | No | Form 4 |
| Kim Helen Susan | Jan 12 | Jan 12 | C · derivative | 3,648,750 | $0.00 | $0 | not reported | No | Form 4 |
| Kim Helen Susan | Jan 12 | Jan 12 | C · derivative | 101,250 | $0.00 | $0 | not reported | No | Form 4 |
| Segal Lloyd Mitchell | Jan 12 | Jan 12 | C | 19,631 | not reported | not reported | 19,631 | No | Form 4 |
| Segal Lloyd Mitchell | Jan 12 | Jan 12 | C · derivative | 50,000 | $0.00 | $0 | not reported | No | Form 4 |
| Segal Lloyd Mitchell | Jan 12 | Jan 12 | C · derivative | 24,687 | $0.00 | $0 | not reported | No | Form 4 |
| Vida Ventures Ii-A, LLC | Jan 12 | Jan 12 | C | 4,859,370 | not reported | not reported | 4,859,370 | No | Form 4 |
| Vida Ventures Ii-A, LLC | Jan 12 | Jan 12 | P | 812,455 | $18.00 | Purchase +$14,624,190 | 5,671,825 | No | Form 4 |
| Vida Ventures Ii-A, LLC | Jan 12 | Jan 12 | C | 134,842 | not reported | not reported | 134,842 | No | Form 4 |
| Vida Ventures Ii-A, LLC | Jan 12 | Jan 12 | P | 22,545 | $18.00 | Purchase +$405,810 | 157,387 | No | Form 4 |
| Vida Ventures Ii-A, LLC | Jan 12 | Jan 12 | C · derivative | 14,838,250 | $0.00 | $0 | not reported | No | Form 4 |
| Vida Ventures Ii-A, LLC | Jan 12 | Jan 12 | C · derivative | 411,750 | $0.00 | $0 | not reported | No | Form 4 |
| Vida Ventures Ii-A, LLC | Jan 12 | Jan 12 | C · derivative | 3,648,750 | $0.00 | $0 | not reported | No | Form 4 |
| Vida Ventures Ii-A, LLC | Jan 12 | Jan 12 | C · derivative | 101,250 | $0.00 | $0 | not reported | No | Form 4 |